Experimental validation of the use of alpha-adrenoblockers in combination with anticoagulants and fibrinolytic agents
Kalishevskaia, T.M.; Golubeva, M.G.; Bashkov, G.V.
Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 3: 24-28
1988
ISSN/ISBN: 0031-2991 PMID: 2902551 Document Number: 322603
Document emailed within 1 workday
Related Documents
Bussey, H.I. 2004: An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves Journal of Heart Valve Disease 13(3): 319-324Diez Tejedor, E.; Barreiro Tella, P.; Acosta Varo, J.; Arpa Gutiérrez, J. 1980: Delayed medical treatment of cerebral ischemic accidents. Therapeutic combination of anticoagulants and platelet antiaggregation agents Archivos de Neurobiologia 43(1): 29-44
Abramchenko, V.V. 1989: Alpha-adrenoblockers and adrenoreceptor function in obstetrical pathology Akusherstvo i Ginekologiia 12: 6-8
Franzosi, M.G. 2001: Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(9): 1034-1036
Klimov, V.N.; Lisienko, V.M.; Krasovskaia, G.A. 1981: Importance of anticoagulants and fibrinolytic preparations in the adjuvant treatment of acute pancreatitis Vestnik Khirurgii Imeni I. I. Grekova 126(2): 120-123
Tadokoro, H. 1977: Experimental study on fibrinolytic phenomena of injured cerebral tissues. With special reference to the changes in fibrinolytic substances in glia tissues Nihon Geka Hokan. Archiv für Japanische Chirurgie 46(3): 258-277
Kryzhanovskiĭ, G.N.; Sheĭkhov, F.D.; Igon'kina, S.I. 1973: The effect of several substances of the phenothiazine series and alpha-adrenoblockers on spinal cord activity with inhibitory mechanisms disrupted by tetanus toxin Farmakologiia i Toksikologiia 36(3): 276-280
Ronchi, W.; Gardelli, G. 1972: Indomethacin in combination with anticoagulants in the treatment thrombophlebitis Minerva Medica 63(3): 180-183
Dantal, J.; Dantal, F.; Sagot, P.; Lopes, P.; Lerat, M.F. 1988: Circulating anticoagulants and pregnancy: a risky combination Journal de Gynecologie Obstetrique et Biologie de la Reproduction 17(3): 317-324
Thorup, S.B.; Husted, S.E.ær.; Vang, M.L. 2014: Monitoring options and reversal agents for oral anticoagulants Ugeskrift for Laeger 176(9)
Griguer, R.P.; Brochier, M.; Raynaud, R. 1973: The place of fibrinolytic and antiplatelet-aggregation agents in therapy Annales de Cardiologie et d'Angeiologie 22(6): 461-472
Arisz, L.; Tegzess, A.M.; Jordans, J.G.; van der Hem, G.K. 1970: Fibrinolytic agents in the management of thrombosed arteriovenous shunt Nederlands Tijdschrift Voor Geneeskunde 114(36): 1484-1490
Vairel, E.G.; Choay, J.; Toulemonde, F. 1983: Current data on fibrinolytic agents used in clinical medicine Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 24(11): 555-558
Laufman, H. 1974: Empiric use of anticoagulant and fibrinolytic agents in surgical therapy American Surgeon 40(1): 15-21
Bhargava, K.P.; Nath, R.; Tangri, K.K. 1976: Effects of anti-inflammatory agents on plasma fibrinolytic activity Indian Journal of Medical Research 64(7): 1094-1098
Melandri, G.; Semprini, F.; Cervi, V.; Candiotti, N.; Branzi, A. 1994: Chronic ischemic cardiopathy: antiplatelet agents and anticoagulants, new protocols for prevention and treatment Cardiologia 39(12 Suppl. 1): 347-352
Hardaway, R.M.; Harke, H.; Williams, C.H. 1994: Fibrinolytic agents: a new approach to the treatment of adult respiratory distress syndrome Advances in Therapy 11(2): 43-51
Horváth, L.; Rauth, J.; Fendler, K.; Molnár, Z.; Romhányi, M. 1985: Management of Leriche syndrome by Dotter's method and oral fibrinolytic agents Orvosi Hetilap 126(11): 651-655
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285
2003: 5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked MMW Fortschritte der Medizin 145(27-28): 58-59